Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Other Operating Expenses (2023 - 2025)

Historic Other Operating Expenses for Bioventus (BVS) over the last 3 years, with Q3 2025 value amounting to $1000.0.

  • Bioventus' Other Operating Expenses changed N/A to $1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$373000.0, marking a year-over-year increase of 6881.27%. This contributed to the annual value of -$292000.0 for FY2024, which is 9183.67% up from last year.
  • As of Q3 2025, Bioventus' Other Operating Expenses stood at $1000.0.
  • Over the past 5 years, Bioventus' Other Operating Expenses peaked at $1000.0 during Q3 2025, and registered a low of -$1.4 million during Q3 2023.
  • Over the past 3 years, Bioventus' median Other Operating Expenses value was -$292000.0 (recorded in 2024), while the average stood at -$564285.7.
  • Over the last 5 years, Bioventus' Other Operating Expenses had its largest YoY gain of 7558.53% in 2024, and its largest YoY loss of 7558.53% in 2024.
  • Over the past 3 years, Bioventus' Other Operating Expenses (Quarter) stood at -$1.2 million in 2023, then surged by 75.59% to -$292000.0 in 2024, then surged by 100.34% to $1000.0 in 2025.
  • Its Other Operating Expenses stands at $1000.0 for Q3 2025, versus -$1000.0 for Q2 2025 and -$81000.0 for Q1 2025.